Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?

To: energyplay who wrote (49057)	4/26/2004 7:22:10 PM
From: TobagoJack	Respond to of 74559

Hi EP, <<I don't know anything about disease diagnostics>> ... same here. I am just helping out a European client with the business/commercial/contractual side of the equation, of a deal that does not involve third party customers, but simply a joint lab to research diseases and their diagnosis. Think of it in the context of global labour arbitrage. <<razor blade business>> is definitely so, and when the blade can be manufactured in China, distributed under brand to global customers, and help to sell more razor, that can then also be made in China (the lower tech/sun-set tech) that can be spread around in China, India, Africa, Latin America, so that the money earned can be used to import some high tech / sun-rise tech into China to seed the hinterlands, then ... Like I like to remind myself, we must be in tune with the Force, tap the Field, modulate the Energy, and be one with What Must Be. The companies that successfully incorporate China into the company's construct, as a source and as a market, will do OK. Companies that fail to do so may do less OK. It is all just math :0) Chugs, Jay